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Abstract
Atopic asthma is a chronic disease of the airways that has taken on epidemic proportions in
the industrialized world. The increase in asthma rates has been linked epidemiologically to the
rapid disappearance of Helicobacter pylori, a bacterial pathogen that persistently colonizes the
human stomach, from Western societies. In this study, we have utilized mouse models of
allergic airway disease induced by ovalbumin or house dust mite allergen to experimentally
examine a possible inverse correlation between H. pylori and asthma. H. pylori infection
efficiently protected mice from airway hyperresponsiveness, tissue inflammation, and goblet
cell metaplasia, which are hallmarks of asthma, and prevented allergen-induced pulmonary
and bronchoalveolar infiltration with eosinophils, Th2 cells, and Th17 cells. Protection against
asthma was most robust in mice infected neonatally and was abrogated by antibiotic
eradication of H. pylori. Asthma protection was further associated with impaired maturation
of lung-infiltrating dendritic cells and the accumulation of highly suppressive Tregs in the
lungs. Systemic Treg depletion abolished asthma protection; conversely, the adoptive transfer
of purified Treg populations was sufficient to transfer protection from infected donor mice to
uninfected recipients. Our results thus provide experimental evidence for a beneficial effect of
H. pylori colonization on the development of allergen-induced asthma.
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Atopic	asthma	is	a	chronic	disease	of	the	airways	that	has	taken	on	epidemic	proportions	in	the	industrial-
ized	world.	The	increase	in	asthma	rates	has	been	linked	epidemiologically	to	the	rapid	disappearance	of	
Helicobacter pylori,	a	bacterial	pathogen	that	persistently	colonizes	the	human	stomach,	from	Western	societ-
ies.	In	this	study,	we	have	utilized	mouse	models	of	allergic	airway	disease	induced	by	ovalbumin	or	house	
dust	mite	allergen	to	experimentally	examine	a	possible	inverse	correlation	between	H. pylori	and	asthma.	
H. pylori	infection	efficiently	protected	mice	from	airway	hyperresponsiveness,	tissue	inflammation,	and	
goblet	cell	metaplasia,	which	are	hallmarks	of	asthma,	and	prevented	allergen-induced	pulmonary	and	
bronchoalveolar	infiltration	with	eosinophils,	Th2	cells,	and	Th17	cells.	Protection	against	asthma	was	most	
robust	in	mice	infected	neonatally	and	was	abrogated	by	antibiotic	eradication	of	H. pylori.	Asthma	protection	
was	further	associated	with	impaired	maturation	of	lung-infiltrating	dendritic	cells	and	the	accumulation	of	
highly	suppressive	Tregs	in	the	lungs.	Systemic	Treg	depletion	abolished	asthma	protection;	conversely,	the	
adoptive	transfer	of	purified	Treg	populations	was	sufficient	to	transfer	protection	from	infected	donor	mice	
to	uninfected	recipients.	Our	results	thus	provide	experimental	evidence	for	a	beneficial	effect	of	H. pylori	
colonization	on	the	development	of	allergen-induced	asthma.
Introduction
Atopic asthma is characterized by lung inflammation, airway hyper-
responsiveness, and airway obstruction (1). The pulmonary infil-
trates of asthmatic patients consist of eosinophils, mast cells, and 
activated Th2 and Th17 cells, which orchestrate allergen-specific 
immune responses (2). In recent decades, the incidence of asthma 
and associated allergic diseases has increased to epidemic propor-
tions in developed countries, especially among children (3). The 
growing prevalence of asthma has been attributed to pollution and 
tobacco smoke (3) and to a lack of infectious stimuli arising from 
modern sanitary practices and the widespread use of antibiotics (4). 
The “hygiene hypothesis” postulates that early exposure to micro-
bial antigens is essential for the normal maturation of the immune 
system and the prevention of allergic diseases (4); it was recently 
revisited by Blaser and Falkow (5), who propose that the loss of 
our ancestral indigenous microbiota, rather than a general decline 
in arbitrary childhood infections, is causally associated with the 
asthma epidemic. In experimental models of asthma, infection with 
microorganisms possessing strong immunomodulatory properties 
has been negatively associated with allergic airway disease (6, 7).
Several epidemiological studies have reported an inverse corre-
lation between asthma incidence and chronic infection with the 
human gastric pathogen Helicobacter pylori (8–11), the causative 
agent of gastric ulcers, gastric lymphoma, and gastric adenocar-
cinoma. This association was strongest in young individuals with 
early-life asthma onset (9) and depended in part on the H. pylori 
virulence determinant CagA (8, 10). We have recently introduced a 
CagA+ H. pylori infection model that recapitulates the gastric pre-
neoplastic histopathology of a subset of H. pylori–infected patients 
(12). In this model, mice that are experimentally infected during 
the neonatal period develop H. pylori–specific immunological tol-
erance and are protected against gastric immunopathology result-
ing from CagA+ infection in adults (12). Here, we have utilized 
models of allergic airway inflammation and hyperresponsiveness 
to examine a possible inverse association between H. pylori infec-
tion and asthma.
Results and Discussion
Experimental infection with H. pylori protects against allergic airway dis-
ease. To experimentally test the effects of H. pylori on OVA-induced 
allergic airway disease, C57BL/6 mice were infected with H. pylori at 
either 6 days or 6 weeks of age (i.e., as neonates or adults), sensitized 
with alum-adjuvanted OVA, and challenged with aerosolized OVA 4 
weeks later to induce asthma-like symptoms. Infection with H. pylori 
significantly reduced airway hyperresponsiveness as evidenced by 
decreased airway resistance following methacholine challenge (Fig-
ure 1A) and alleviated the peribronchiolar and perivascular inflam-
mation and goblet cell metaplasia that are hallmarks of asthma 
(Figure 1, B and C). The infiltration of immune cells into the bron-
choalveolar lavage fluid (BALF) as well as the increase of eosino-
phils and concomitant relative decrease of alveolar macrophages in 
BALF was largely prevented in infected mice (Figure 1, D–F). Final-
ly, the secretion of IL-5 into the BALF and the pulmonary infiltra-
tion of Th2 and Th17 cells as detected by flow cytometric analysis 
of lung single cell preparations were diminished in infected animals 
(Figure 1G and Supplemental Figure 1; supplemental material 
available online with this article; doi:10.1172/JCI45041DS1). Most 
indicators of asthma were more strongly reduced in neonatally 
infected than in adult-infected mice (Figure 1, A–G), suggesting 
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Figure 1
Experimentally induced asthma is alleviated by H. pylori infection. Mice were orally infected as neonates (iN) or adults (iA) with H. pylori and 
sensitized with alum-adjuvanted OVA (A–G) or HDM (H–M) 4 and 6 weeks after infection along with an uninfected (uninf) group. 1 group of 
neonatally infected mice received antibiotic therapy between the first and second allergen doses. 2 weeks after the second sensitization, all 
mice (including a mock-sensitized control group [PBS]) were exposed to 3 consecutive daily doses of aerosolized OVA or intranasal HDM. (A, 
H) Airway hyperresponsiveness in response to increasing doses of methacholine and the highest dose of 100 mg/ml, respectively (upper and 
lower panels in A). (B, C, I, and J) Tissue inflammation and goblet cell metaplasia as assessed on H&E- and PAS-stained tissue sections. 
Representative micrographs are shown in B and I; inflammation and PAS scores are shown in C and J. Original magnification, ×100 (H&E); 
×400 (PAS). (D and K) Total cells contained in 1 ml of BALF. (E) Relative representation of the indicated cell types in BALF. (F and L) Absolute 
numbers of eosinophils in 1 ml of BALF. (G and M) IL-5 and/or IL-13 secretion as assessed by cytometric bead array. *P < 0.05 and **P < 0.01 
in comparison with uninfected, but allergen-treated, controls. All group data of methacholine measurements are presented as mean ± SEM. 
Total cell and eosinophil counts in BALF are presented for individual mice, with horizontal bars indicating group medians. Inflammation scores 
and PAS+ cells are represented by box and whisker plots, with horizontal bars representing medians and whisker ends indicating minimal and 
maximal values. Cytokine measurements and PCR results are presented as group mean ± SD.
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a continuum of protection that is inversely correlated with age at 
the time of infection. Interestingly, antibiotic eradication therapy 
resulting in efficient killing of the bacteria after the sensitization 
phase of our protocol abrogated asthma protection (Figure 1, A–G). 
To rule out that asthma protection in infected mice is due to their 
defect in generating a primary allergen-specific immune response, 
we compared OVA-specific responses in infected and uninfected 
mice. All mice generated similar OVA-specific IgE titers and spleno-
cyte recall responses (Supplemental Figure 2), indicating that the 
infection status does not affect the primary responses to allergen. 
To verify our results in another model of allergic airway disease, we 
alternatively utilized house dust mite (HDM) allergen for sensiti-
zation and intranasal challenge. HDM-sensitized/challenged mice 
showed robust airway responses similar to those of OVA-treated 
mice (Figure 1, H-M). As observed in the OVA model, neonatally 
infected mice were protected against HDM-induced airway hyper-
responsiveness as assessed by methacholine challenge (Figure 1H) 
and exhibited significantly less peribronchiolar and perivascular 
inflammation and goblet cell metaplasia than uninfected controls 
(Figure 1, I and J). Their bronchoalveolar inflammation, eosino-
philia, and IL-5 and IL-13 secretion were clearly reduced (Figure 1, 
K–M). Mice infected as adults did not benefit from H. pylori in the 
HDM model (Figure 1, H–M). In conclusion, we show here that 
infection with H. pylori, especially early in life, is protective against 
asthma in mouse models of the disease.
H. pylori–mediated asthma protection is associated with increased pulmo-
nary Treg infiltration and impaired DC maturation. Multiple recent stud-
ies have highlighted a functional role of CD4+FoxP3+ Tregs in con-
trolling allergic Th2 cell responses (13). To examine a role of Tregs 
in H. pylori–mediated asthma protection, we first assessed pulmo-
nary FoxP3+ Treg infiltration in the OVA-induced asthma model. 
Neonatally infected mice exhibited higher numbers of pulmonary 
CD4+FoxP3+ Tregs than uninfected mice, whereas adult-infected 
mice showed an intermediate phenotype (Figure 2, A–C). Immuno-
magnetic isolation of pulmonary CD4+CD25+ Tregs from neona-
tally infected, OVA-challenged mice revealed that this Treg popula-
tion has strong suppressive activity ex vivo (Supplemental Figure 3). 
Another characteristic feature of neonatally infected mice was their 
pulmonary infiltration by semimature DCs with low to intermedi-
ate MHCII expression, which are believed to induce peripheral T cell 
tolerance (14); in contrast, mature MHCIIhi DCs constituted the pre-
dominant DC population in asthmatic lungs of uninfected or adult-
infected animals (Figure 2, D and E). Consequently, the MHCIIhi/ 
MHCIIint ratio was higher in the latter groups (Figure 2F). These 
results suggest a causal relationship between H. pylori–mediated 
asthma protection and lung infiltration by “tolerogenic” immune 
cell populations such as Tregs and semimature DCs.
Asthma protection conferred by H. pylori infection is mediated by 
Tregs. Two recent epidemiological studies have revealed an inverse 
association of asthma with seropositivity for the H. pylori immu-
Figure 2
Tregs and semimature DCs accumulate in the lungs of neonatally infected mice. Groups of mice treated as described in Figure 1 were analyzed 
with respect to lung infiltration by FoxP3+ Tregs and CD11c+B220– DCs. (A and B) Representative scatter plots and quantification of CD4+FoxP3+ 
cells in lung preparations of 4–6 mice per group; percentages in A denote the fraction of CD4+FoxP3+ cells of all lung cells. (C) foxP3 expression 
of the mice shown in B, normalized to GAPDH. (D and E) Representative scatter plots and quantification of CD11c+B220– DCs expressing high 
and intermediate levels of MHCII; percentages in D denote the fractions of MHCIIhi and MHCIIint cells of all CD11c+B220– lung DCs. (F) Ratios 
of MHCIIhi/MHCIIint DCs as calculated per mouse. All group data of methacholine measurements are presented as mean ± SEM. Total cell and 
eosinophil counts in BALF are presented for individual mice, with horizontal bars indicating group medians. Inflammation scores and PAS+ cells 
are represented by box and whisker plots, with horizontal bars representing medians and whisker ends indicating minimal and maximal values. 
Cytokine measurements and PCR results are presented as group mean ± SD.
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nodominant antigen CagA, implying that infection with CagA+ 
H. pylori strains is particularly beneficial with regard to asthma 
prevention (8, 10). The H. pylori strain used here harbors a cagA 
gene as well as the type IV secretion system (T4SS) required for 
CagA delivery to host cells (12). To determine whether CagA 
delivery is required for asthma protection, we first verified that 
H. pylori reisolates retain their ability to deliver CagA in vitro 
after prolonged coexistence with their murine hosts (Supple-
mental Figure 4A). We then infected neonatal mice with either 
wild-type H. pylori or an isogenic mutant lacking an essential 
component of the T4SS (ΔCagE). H. pylori ΔCagE–infected ani-
mals were protected at least as well as wild-type infected mice 
from OVA-induced asthma as determined by assessment of air-
way resistance, histopathology, and airway eosinophilia (Sup-
plemental Figure 4, B–F), indicating that CagA delivery is not a 
prerequisite for asthma protection in this model.
Figure 3
Asthma protection is conferred by Tregs. Groups of mice were sensitized with OVA or PBS only prior to intravenously receiving unsorted (total [tot]) 
MLN/PP populations isolated from uninfected or neonatally infected and/or OVA-sensitized or Treg-depleted (–FoxP3+) donors. Tregs were depleted 
in foxP3-EGFP-DTR–transgenic donors by a single dose of diphtheria toxin 1 day prior to cell isolation; Treg-proficient donors were nontransgenic 
littermates. Additional recipients received 2.5 × 105 immunomagnetically isolated, MLN/PP-derived CD4+CD25+ Tregs or CD4+CD25– T cells (>85% 
purity each) from neonatally infected donors. All recipients as well as control groups were nebulized with OVA on days 2, 3, and 4 after adoptive 
transfer and sacrificed 2 days later. (A) Airway hyperresponsiveness in response to increasing doses of inhaled methacholine and the highest dose 
of 100 mg/ml, respectively. (B and C) Total cells and eosinophils contained in 1 ml of BALF. (D and E) Tissue inflammation and goblet cell metapla-
sia as assessed on H&E- and PAS-stained tissue sections. Micrographs of representative T cell recipients and controls are shown in D; inflamma-
tion and PAS scores are shown in E for all mice. Original magnification: ×100 (H&E); ×400 (PAS). All group data of methacholine measurements 
are presented as mean ± SEM. Total cell and eosinophil counts in BALF are presented for individual mice, with horizontal bars indicating group 
medians. Inflammation scores and PAS+ cells are represented by box and whisker plots, with horizontal bars representing medians and whisker 
ends indicating minimal and maximal values. Cytokine measurements and PCR results are presented as group mean ± SD.
brief report
3092	 The	Journal	of	Clinical	Investigation	 	 	 http://www.jci.org	 	 	 Volume 121	 	 	 Number 8	 	 	 August 2011
To determine whether the protection conferred by neonatal 
H. pylori infection depends on Tregs, we depleted Tregs by anti-
CD25 mAb treatment during OVA challenge. This treatment was 
sufficient to largely abrogate protection (Supplemental Figure 
4, B–F). We next tested to determine whether asthma protection 
can be adoptively transferred from infected donors to uninfected 
recipients using specific immune cell populations. We isolated 
mesenteric lymph node and Peyer patch (MLN/PP) cell popula-
tions from mice that had been infected as neonates and/or had 
been sensitized with OVA and systemically depleted of Tregs. 
Asthma protection was successfully conferred by adoptive trans-
fer of 1 × 107 MLN/PP cells from neonatally infected, but not 
uninfected, donors as determined by methacholine challenge, 
histopathological analysis, and quantification of bronchoalveo-
lar infiltration, eosinophilia, and IL-5 production; prior exposure 
of the donors to OVA was not a prerequisite for protection (Fig-
ure 3, A–E, and Supplemental Figure 5). In contrast, prior deple-
tion of Tregs in the infected donors reduced protection (Figure 
3, A–E). In line with this result, as few as 2.5 × 105 adoptively 
transferred, immunomagnetically purified, MLN/PP-derived 
CD4+CD25+ Tregs, but not CD4+CD25– conventional T cells, 
were sufficient to confer protection (Figure 3, A–E).
In summary, we conclude that H. pylori prevents allergic airway 
disease in preclinical models; we attribute protection against asth-
ma to the immunomodulatory properties of H. pylori based on the 
following observations. Protection is particularly evident in neona-
tally infected mice, which develop H. pylori–specific immunologi-
cal tolerance mediated by long-lived, inducible Tregs (12). Tregs 
with suppressive activity accumulate in the lungs of neonatally 
infected, protected mice. Their depletion abrogates protection, and 
the adoptive transfer of purified Tregs alone is sufficient to confer 
protection. Based on our finding of semimature DC infiltration 
into the lungs of protected mice, we speculate that neonatally 
induced Tregs retain lung-infiltrating DCs in a semimature state. 
An analogous mechanism was proposed recently by Onishi et al., 
who found that FoxP3+ Tregs form aggregates on DCs, actively 
downregulate their costimulatory molecules, and impair the DCs’ 
ability to activate antigen-specific T cells (15).
Several viral and parasitic pathogens, including influenza viruses 
and helminths, have been implicated in protection against asthma 
and allergy (6, 7, 16); additional observations point to H. pylori as 
a plausible causative agent in asthma protection. First, H. pylori is 
rapidly disappearing from human populations; its disappearance 
is evident as a birth cohort effect, with fewer than 10% of children 
still harboring H. pylori in industrialized countries compared with 
the historic 70%–90% (17). The decline in H. pylori infection rates 
has preceded a rise in the prevalence of asthma and other atopic 
diseases in developed countries (3). Numerous case-control and 
cross-sectional studies have reported an inverse association of 
H. pylori infection with asthma, allergic rhinitis, and atopic der-
matitis, especially in young individuals with early-onset disease 
(reviewed in ref. 11). H. pylori–infected children are known to pref-
erentially launch Treg responses to the pathogen (18), which may 
account for the particularly beneficial effects of H. pylori in this 
population. In conclusion, our model of H. pylori–mediated asth-
ma protection provides experimental support for the “disappear-
ing microbiota” hypothesis (5), which postulates that the asthma 
and allergy epidemic of modern societies is a direct consequence 
of the disappearance of our ancestral indigenous microflora, 
which included H. pylori.
Methods
Animal experimentation. C57BL/6 mice (Charles River) were orally infected with 
H. pylori PMSS1 or an isogenic CagE-deficient mutant (12). Infections and 
antibiotic therapy were performed as described (12). Mice were sensitized by 
i.p. injection of 20 μg OVA (Sigma-Aldrich) or 20 μg HDM allergen (Derma-
tophagoides pteronyssinus; Greer Laboratories) emulsified in 2.25 mg aluminum 
hydroxide (Alum Imject; Pierce) at 4 and 6 weeks after infection OVA-sensitized 
mice were challenged with 1% aerosolized OVA using an ultrasonic nebulizer 
(NE-U17; Omron) for 20 minutes daily on days 31, 32, and 33 after initial sen-
sitization. HDM-sensitized animals were anesthetized on days 31, 32, and 33 
by i.p. injection of ketamine/Rompun (Ketamine-Ratiopharm/Rompun 2%) 
and received 25 μg HDM allergen in 50 μl PBS intranasally. Airway resistance 
measurements were performed on anesthetized, intubated, and mechanically 
ventilated mice (flexiVent; Scireq) in response to increasing doses of inhaled 
methacholine (19). In vivo depletion of Tregs was achieved by 3 i.p. injections 
of 100 μg of anti-CD25 antibody (clone PC61) or by administration of diph-
theria toxin to foxP3-EGFP-DTR–transgenic mice as described (12). MLN/PP 
single cell preparations and immunomagnetic cell sorting of CD4+CD25+ cells 
were performed as described (12). All animal experimentation was approved by 
the Zurich Cantonal Veterinary Office (Zurich, Switzerland).
BAL, histopathology, lung single cell preparation, flow cytometry, and real-time 
RT-PCR. Lungs were lavaged via the trachea with 1 ml PBS. BALF cells were 
counted using Trypan blue dye exclusion. Differential cell counts of mac-
rophages, lymphocytes, neutrophils, and eosinophils were performed on 
cytocentrifuged preparations stained with the Microscopy Hemacolor-Set 
(Merck). Cytokines in BALF were quantified by cytometric bead array (BD). 
Lungs were dissected, enzymatically digested with 0.5 mg/ml collagenase type 
IA (Sigma-Aldrich), and pushed through a 70-μm nylon cell strainer. The anti-
bodies were anti-CD4 (clone H129.19), anti–I-Ab (clone AF6-120.1), anti-B220 
(RA3-6B2), anti-CD11c (clone HL3), anti–IL-5 (clone TRFK5; all BD Biosci-
ences — Pharmingen), anti-Foxp3 (FJK-16s), and anti–IL-17A (TC11-18H10.1, 
both eBioscience). Lungs were fixed by inflation and immersion in 10% for-
malin and embedded in paraffin. Tissue sections were stained with H&E and 
periodic acid-Schiff and examined in blinded fashion on a BX40 Olympus 
microscope. Peribronchial inflammation was scored on a scale from 0 to 4. 
PAS-positive goblet cells were quantified per 1 mm of basement membrane. 
FoxP3 real-time RT-PCR was performed as described previously (12).
Statistics. All statistical analysis was performed using Graph Pad prism 
5.0 software. The significance of categorical and numerical differences 
was calculated by Mann-Whitney and 2-tailed Student’s t test, respectively. 
P < 0.05 was considered significant. 
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